SRSF5
Serine/arginine-rich splicing factor 5
Also known as: HRS, SFRS5, SRP40, SRSF5_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13243
- Gene
- SRSF5
- Ensembl
- ENSG00000100650
- Chromosome
- 14
- Canonical length
- 272 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
Canonical amino-acid sequenceUniProt
272 residues, UniProt reviewed canonical sequence.
>Q13243|SRSF5
1 MSGCRVFIGR LNPAAREKDV ERFFKGYGRI RDIDLKRGFG FVEFEDPRDA DDAVYELDGK
61 ELCSERVTIE HARARSRGGR GRGRYSDRFS SRRPRNDRRN APPVRTENRL IVENLSSRVS
121 WQDLKDFMRQ AGEVTFADAH RPKLNEGVVE FASYGDLKNA IEKLSGKEIN GRKIKLIEGS
181 KRHSRSRSRS RSRTRSSSRS RSRSRSRSRK SYSRSRSRSR SRSRSKSRSV SRSPVPEKSQ
241 KRGSSSRSKS PASVDRQRSR SRSRSRSVDS GNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SRSF5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 431 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 431 nTPM
- skin: 260 nTPM
- fallopian tube: 241 nTPM
- small intestine: 239 nTPM
- choroid plexus: 235 nTPM
- blood vessel: 230 nTPM
Single-cell type
- esophageal apical cells: 3,025 nCPM
- syncytiotrophoblasts: 965 nCPM
- migrating cytotrophoblasts: 630 nCPM
- epididymal basal cells: 623 nCPM
- epididymal principal cells: 601 nCPM
- esophageal suprabasal cells: 557 nCPM
Immune cell
- neutrophil: 163 nTPM
- basophil: 138 nTPM
- non-classical monocyte: 130 nTPM
- intermediate monocyte: 118 nTPM
- memory B-cell: 110 nTPM
- naive B-cell: 109 nTPM
Brain region
- choroid plexus: 245 nTPM
- white matter: 179 nTPM
- cerebral cortex: 161 nTPM
- medulla oblongata: 140 nTPM
- hippocampal formation: 139 nTPM
- pons: 136 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.69
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to insulin stimulus
- liver regeneration
- mRNA processing
- mRNA splice site recognition
- positive regulation of RNA splicing
- regulation of alternative mRNA splicing, via spliceosome
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SRSF5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SRSF5 as an antibody target. Whether an autoantibody or antibody against SRSF5 could matter depends on whether native SRSF5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SRSF5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SRSF5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...